Mettler-Toledo International, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5926881054
USD
1,422.81
-12.07 (-0.84%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Mettler-Toledo International, Inc. stock-summary
stock-summary
Mettler-Toledo International, Inc.
Pharmaceuticals & Biotechnology
Mettler-Toledo International Inc. is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications. The Company is also a provider of analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development, and process analytics instruments used for in-line measurement in production processes. In addition, the Company is also a supplier of end-of-line inspection systems used in production and packaging for food, pharmaceutical and other industries. The Company serves food and beverage producers; food retailers; chemical, specialty chemicals and cosmetics companies, and the transportation and logistics industry, among others.
Company Coordinates stock-summary
Company Details
1900 Polaris Pkwy , COLUMBUS OH : 43240-4035
stock-summary
Tel: 1 614 43845111 614 4384748
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 154 Schemes (45.33%)

Foreign Institutions

Held by 402 Foreign Institutions (33.53%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Robert Spoerry
Independent Chairman of the Board
Mr. Oliver Filliol
President, Director
Mr. Wah-Hui Chu
Independent Director
Ms. Domitille Doat-Le Bigot
Independent Director
Ms. Elisha W. Finney
Independent Director
Mr. Richard Francis
Independent Director
Mr. Michael Kelly
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
983 Million
(Quarterly Results - Jun 2025)
Net Profit:
202 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 55,740 Million (Mid Cap)

stock-summary
P/E

59.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-8.20

stock-summary
Return on Equity

-312.94%

stock-summary
Price to Book

-215.39